Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,019,761
+$2,665,285 QoQ
Shares Held
171,874
+3.1% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 383 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 96% None 4%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. PTCT ranks #49 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,604,822 $1,293,893,227
2 INSM
INSMED Inc
 6,179,571 $658,865,856
3 JAZZ
Jazz Pharmaceuticals plc
 1,215,523 $292,904,576
4 RVMD
Revolution Medicines, Inc.
 1,039,702 $194,715,388
5 ARGX
Argenx SE
 181,464 $168,356,853
6 REGN
Regeneron Pharmaceuticals, Inc.
 227,457 $141,828,535
7 MDGL
Madrigal Pharmaceuticals, Inc.
 231,205 $124,145,521
8 BBIO
BridgeBio Pharma, Inc.
 1,551,663 $115,567,858

All Filings in PTCT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,019,761 171,874
2026-03-31 $11,354,476 166,659
2025-12-31 $11,210,479 147,584
2025-09-30 $652,362 10,630
2025-06-30 $519,168 10,630
2025-03-31 $925,585 18,163
2024-12-31 $1,938,040 42,934
2024-09-30 $2,562,125 69,060
2024-06-30 $2,411,293 78,852
2024-03-31 $2,142,507 73,651
2023-12-31 $2,025,604 73,498
2023-09-30 $14,247,782 635,778
2023-06-30 $16,316,233 401,186
2023-03-31 $3,926,304 81,055
2022-12-31 $1,982,702 51,944
2022-09-30 $876,893 17,468
2022-06-30 $712,626 17,789
2022-03-31 $672,250 18,018
2021-03-31 $559,060 11,807
2020-12-31 $1,685,159 27,612
2020-09-30 $1,937,319 41,440
2020-06-30 $2,942,412 57,990
2020-03-31 $2,312,805 51,845